Alcidion Group Limited · ASX:ALC
Alcidion — Shareholder Meeting (November 2026)
35 slides from Alcidion's shareholder meeting presentation, Nov 12, 2026
Slide 1: 2026 Annual General Meeting Chair Address and Presentation
12 November 2026 For personal use only Australian Securities Exchange 39 Martin Place Sydney NSW 2000 2026 Annual General Meeting Chair Address and Presentation Melbourne, Australia – Alcidion Group Limited (ASX: ALC) (Alcidion or Company) advises in accordance with ASX Listing Rule 3.13.3, a copy o
Slide 2: Chair's Address
Chair’s Address Good afternoon, everyone, and thank you for joining us for Alcidion's 2026 Annual General Meeting. For personal use only FY26 was a standout year for Alcidion. It was the year we moved decisively from transformation to traction, and it has set the foundation for continued growth over
Slide 3: Chair's Address (continued)
These priorities complement one another, and we will manage them in a careful and measured way, always weighing which offers the best long-term return. For personal use only The on-market share buy-back is one example. It reflects the Board's confidence in Alcidion's outlook and gives us a lever wit
Slide 4: Annual General Meeting November 2026
rsonal use only Annual General Meeting 12 November 2026
Slide 5: Introduction
rsonal use only INTRODUCTION
Slide 6: Acknowledgement of Country
rsonal use only ACKNOWLEDGEMENT OF COUNTRY Alcidion acknowledges the Traditional Custodians of the land we live and work upon and pay our respects to Elders past and present. COMMERICAL IN CONFIDENCE
Slide 7: Alcidion Group Board
Alcidion Group Board rsonal use only Rebecca Wilson Kate Quirke Daniel Sharp Andrew Way William Smart Non-executive Chair Group Managing Director/ Non-executive Director Non-executive Director Non-executive Director Chief Executive Officer Experienced company director with 25+ years of digital healt
Slide 8: Format of Meeting
Format of Meeting rsonal use only 01 02 Chair Address Annual General Meeting Presentation 03 04 Q&A / Voting Procedure Formal Business of the Overview Meeting 05 General Questions
Slide 9: Chair Address
rsonal use only 01. Chair Address
Slide 10: Annual General Meeting Presentation
rsonal use only 02. Annual General Meeting Presentation
Slide 11: FY26 AGM CEO Presentation
rsonal use only FY26 AGM CEO Presentation 12 November 2026
Slide 12: FY26 Snapshot
rsonal use only FY26 Snapshot
Slide 13: A Record FY26 for Alcidion
A Record FY26 for Alcidion… 1 2 3 4 rsonal use only Growth Profitability Referenceability Market Need Revenue up 27%1 Underlying EBITDA up Multiple Flagship Healthcare systems 34% customer expansions + under increasing new EPR win pressure to improve Operating cashflow up efficiency & bed 19% availa
Slide 14: FY26 – Financial Highlights
FY26 – Financial Highlights Growth across all key financial metrics rsonal use only Revenue ARR2 (as at 30 Jun-26) New & renewal TCV EBITDA3 Positive operating cashflow $51.6M $38.3M $78.5M $6.2M $6.8M Up 27% on pcp 1 Up 34% on pcp Up 6% on pcp Up 28% on pcp Up 19% on pcp Driven by several contract
Slide 15: FY26 – Operational Highlights
FY26 – Operational Highlights Continuing sales momentum + strategic patient flow acquisition rsonal use only New + expanded contracts Extensions / Renewals Kyra Flow Products Acq. Mizaic partnership + Patientrack › Completed acquisition on 29 June non- clinical comms 2026 › Added 33 new customers (3
Slide 16: Growing Customer Footprint
Growing Customer Footprint 100+ healthcare clients across the UK, Australia and NZ - from NHS trusts to defence health United Kingdom 40+ NHS trusts(1) Australia & New Zealand Every Australian state and territory(1) rsonal use only 1 NHS Fife 1 Kyra flow products Patientrack observations and Smartpa
Slide 17: Miya Patient Administration
rsonal use only Miya Patient Administration
Slide 18: Introducing Miya Patient Administration
Introducing Miya Patient Administration The MIYA Platform rsonal use only ✓ Clinical documentation (e-noting) ✓ Longitudinal patient record ✓ Observations and fluid balance ✓ Clinical decision support ✓ Bed and capacity management ✓ Medications Management* ✓ Allergies, alerts, problems & diagnoses ✓
Slide 19: Built from the ground up, not anchored in the past
Built from the ground up, not anchored in the past rsonal use only THE DEPTH OF PCS PAS 30 Using AI to deeply analyse the requirements from our PCS PAS blueprint. BUILT NEW ON MIYA Built from the ground up on Miya’s modern platform. YEARS of patient administration experience carried forward SHAPED W
Slide 20: Taking advantage of the latest technology to transform patient administration
We are taking advantage of the latest technology to transform patient administration rsonal use only 01 02 03 04 SEAMLESS INTEGRATED INTUITIVE INTELLIGENT Streamlined Natively, with one Like the best Always looking management of record for every colleague you’ve ahead the patient’s care perspective
Slide 21: Miya as the System of Record
Miya as the System of Record Deepening our capability as the core system of record for healthcare organisations • AI enablement rsonal use only doctor Icon 1194893 Scenario 1 Scenario 2 • Results Management • Task Management • Longitudinal Patient Record System of • Patient Flow Management Engagemen
Slide 22: Growth Strategy & Outlook
rsonal use only Growth Strategy & Outlook
Slide 23: Evolving our AI capability in Healthcare
Evolving our AI capability in Healthcare Embracing the use of AI workflows whilst understanding and protecting client data/security rsonal use only ledge Retrieva Know l The Alcidion AI Framework Do 01 Knowledge Retrieval Conversational (Conversational AI) cu m AI en tat ion ion Act 02 Documentation
Slide 24: Growth Drivers
Growth Drivers Multiple growth drivers underpinned by increasing customer referenceability rsonal use only 4 Alcidion in the Future Disciplined platform 3 expansion › Leading recurring-revenue healthcare technology Deepen platform • M&A opportunities platform 2 capabilities for complementary Win new
Slide 25: Capital Management & Outlook
Capital Management & Outlook Growing contracted revenue underpins confidence in future profitability and capital returns rsonal use only Capital Management Outlook • Driven by improving profitability and cash generation, the • As of 30 September 2026, contracted & renewal revenue Board has greater f
Slide 26: Q&A / Voting Procedure Overview
rsonal use only 03. Q&A / Voting Procedure Overview
Slide 27: Formal Business of the Meeting
rsonal use only 04. Formal Business of the Meeting
Slide 28: Financial Statements and Reports
Financial Statements and Reports rsonal use only To receive and consider the Company’s Financial Statements, Directors’ Report and Auditor’s Report for the financial year ended 30 June 2026. Further Information › Matthew Gepp, Chief Financial Officer of Alcidion Group Limited and Grant Martinella of
Slide 29: Resolution – Adoption of Remuneration Report
Resolution 1 – Adoption of Remuneration Report rsonal use only To consider and, if thought fit, pass the following as an ordinary resolution: “That for the purpose of section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as
Slide 30: Resolution – Re-election of Rebecca Wilson as a Director
Resolution 2 – Re-election of Rebecca Wilson as a Director rsonal use only To consider and, if thought fit, pass the following as an ordinary resolution: "That, Rebecca Wilson, being a Director who retires by rotation pursuant to Clause 21.1 of the Constitution and Listing Rule 14.4 and who, being e
Slide 31: Resolution – Consolidation of Capital
Resolution 3 – Consolidation of Capital To consider and, if thought fit, pass the following as an ordinary resolution: rsonal use only "That, pursuant to section 254H of the Corporations Act, Listing Rules 7.20 and 7.21 and for all other purposes, approval is given for the issued capital of the Comp
Slide 32: Voting Closure and End of Formal Business
rsonal use only VOTING CLOSURE AND END OF FORMAL BUSINESS
Slide 33: General Questions
rsonal use only 05. General Questions
Slide 34: Thank You for Your Attendance
rsonal use only THANK YOU FOR YOUR ATTENDANCE
Slide 35: rsonal use only
Z O 2 Y < 3 Ajuo asn jeuosie